Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MakoLabWAR:MLB -0.52%78 EBIT per Share is zł1.04 as of Mar. 2026. GuruFocus rates WAR:MLB with a GF Score™ of 78/100 and a GF Value™ of zł5.26 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 2,121 Software companies, MakoLab ranks better than 52.15% on this metric.
MakoLab's EBIT per Share for the
three
months ended in Mar. 2026 was zł0.28.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was zł1.04.
During the past 12 months, the average EBIT per Share Growth Rate of MakoLab was 24.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 13.20% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 14.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 9.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for MakoLab's EBIT per Share or its related term are showing as below:
WAR:MLB'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -13.8 Med: 14.4 Max: 93
Current: 13.2
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of MakoLab was 93.00% per year. The lowest was -13.80% per year. And the median was 14.40% per year.
WAR:MLB's 3-Year EBIT Growth Rate is ranked better than 52.15% of 2121
companies
in the Software industry
Industry Median: 11.9
vs WAR:MLB: 13.20
MakoLab's EBIT for the
three
months ended in Mar. 2026 was zł1.92 Mil.
MakoLab (WAR:MLB) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
MakoLab EBIT per Share Related Terms
MakoLab EBIT per Share Historical Data
* Premium members only.
The historical data trend for MakoLab's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was zł1.04
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MakoLab (WAR:MLB) has a EBIT per Share of zł1.04 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MakoLab and its competitors. According to the industry distribution chart, MakoLab ranks #1015 out of 2121 companies in the Software industry, placing it in the top 47.9%.
Is MakoLab's EBIT per Share too high?
MakoLab's current EBIT per Share is zł1.04. Based on the distribution chart, MakoLab ranks #1015 out of 2121 companies in the Software industry, which is above the industry midpoint. Overall, MakoLab has a GF Score™ of 78/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MakoLab's EBIT per Share compare to IBM and ACN?
According to the Software industry distribution chart, MakoLab ranks #1015 out of 2121 companies for EBIT per Share. This puts MakoLab in the upper half of its industry. The industry median EBIT per Share is 11.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Software company?
The median EBIT per Share among Software companies is 11.90, based on 2,121 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on MakoLab and its competitors. For the Software industry, the median EBIT per Share is 11.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MakoLab's current EBIT per Share is zł1.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MakoLab stock overvalued right now?
Based on GuruFocus' analysis, MakoLab (WAR:MLB) is currently considered Significantly Overvalued. The stock's GF Value™ is zł5.26, compared to a current price of zł9.65 — trading 83.5% above its estimated fair value. The current EBIT per Share is zł1.04. MakoLab's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For MakoLab (WAR:MLB), the current EBIT per Share is zł1.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MakoLab (WAR:MLB) Overvalued in 2026?
Based on GuruFocus' analysis, MakoLab stock appears to be overvalued.
The current stock price of zł9.65 is trading 83.5% above its estimated GF Value™ of zł5.26.
GuruFocus considers MakoLab to be Significantly Overvalued.
Key valuation signals for WAR:MLB:
EBIT per Share: zł1.04
GF Value™: zł5.26 vs. price of zł9.65 (83.5% above fair value)
No single metric tells the full story. See the WAR:MLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MakoLab SA engaged in the provision of technology and marketing solutions in Poland. It is engaged in the creation and implementation of Web solutions, including Web services, portals, WWW pages, and visual projects; and provision of maintenance and management services of IT resources. The company serves Automotive, Finance, Banking and Insurance, Commercial Real Estate, Public sector, Culture and Education, Lifestyle, and Tourism, Travelling and Leisure.
78GF Score
Get the complete analysis for WAR:MLB
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:MLB has been successfully added to your 
